Alnylam Pharmaceuticals, Inc. (ALNY)
328.28
-0.42
(-0.13%)
USD |
NASDAQ |
Mar 26, 16:00
328.28
0.00 (0.00%)
After-Hours: 16:24
Alnylam Pharmaceuticals Market Cap : 43.54B for March 26, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 156.77B |
| Eli Lilly & Co. | 801.32B |
| Regeneron Pharmaceuticals, Inc. | 80.00B |
| Bristol Myers Squibb Co. | 120.97B |
| Insmed, Inc. | 31.80B |
Market Cap Related Metrics
| PE Ratio | 145.44 |
| PS Ratio | 11.80 |
| Price to Book Value | 55.17 |
| Price to Free Cash Flow | 94.16 |
| Price | 328.28 |
| Earnings Yield | 0.69% |
| Operating PE Ratio | 87.36 |
| Normalized PE Ratio | 131.84 |